Skip to main content

Acute Heart Failure syndrome made simple

  • Acute heart failure syndrome (AHFS) spectrum can be divided into 5 groups as regards therapeutic management
    • (i) Dyspnoea + /- congestion with elevated systolic blood pressure (SBP)>140 mmHg, usually with abrupt onset (acute pulmonary oedema) APO (most frequent type)
    • (ii) Dyspnoea + /- congestion with normal SBP 100-140 mmHg, usually with gradual onset predominant systemic oedema and milder APO
    • (iii) Dyspnoea + /- congestion with low SBP <100 mmHg, with predominant cardiogenic shock or end-stage cardiac failure (most fatal type)
    • (iv) Dyspnoea + /- congestion with signs of ACS such as chest pain
    • (v) Isolated RV failure usually without APO.

  • Treatment aims

    • Decrease left ventricular diastolic pressure, by decreasing systemic vascular resistance and improving systolic and diastolic functional reserve.
    • Promote coronary blood flow.
    • Correct acute respiratory failure.
    • In-hospital mortality for APO is up to 12%, with one-year mortality up to 40%.

  • Drugs

    • Nitroglycerin S/L, topical or IV titrated to avoid hypotension.
      • Most rapidly venodilates, reduces LV afterload and corrects myocardial ischaemia. Ideal for AHFS type 1. (i) above.
      • Also consider in AHFS types 1. (ii) and (iv) if SBP > 110 mmHg.
      • Avoid in AHFS type 1. (iii) above.
      • Nitrates are used less often than frusemide + were used in just 27% of the patients admitted in the ADHERE registry (USA, 2003)

    • Frusemide IV.  Despite universal use, absolute efficacy is unclear. May cause decrease in cardiac output and increase PVR, plus increase PAOP in more chronic HF. Ideal for AHFS type 1. (ii) above.

    • ACE inhibitor IV, orally or SC also reduces pre- and afterload, but little data in acute situation. Precipitous hypotension is hard to reverse, so use is best reserved for longer term management of HF.

    • Morphine has relatively ineffective / unproven acute venodilating and sympatholytic effects, is rarely used (3% one study) and may result in respiratory depression in face of NIV and/or a poorer outcome. May have role in APO with diastolic dysfunction (ie. EF >40%) with elevated SBP.

    • Traditional inotropic support is with dobutamine, dopamine, milrinone, enoximone or salbutamol for AHFS type 1. (iii) above, but may disastrously increase myocardial oxygen demand, especially in ACS with AHFS type 1. see (iv) above. Rarely need to add vasoconstrictor noradrenaline.

Comments

Popular posts from this blog

Driving Pressure in ARDS: A new concept!

Driving Pressure and Survival in the Acute Respiratory Distress Syndrome Marcelo B.P. Amato, M.D., Maureen O. Meade, M.D., Arthur S. Slutsky, M.D., Laurent Brochard, M.D., Eduardo L.V. Costa, M.D., David A. Schoenfeld, Ph.D., Thomas E. Stewart, M.D., Matthias Briel, M.D., Daniel Talmor, M.D., M.P.H., Alain Mercat, M.D., Jean-Christophe M. Richard, M.D., Carlos R.R. Carvalho, M.D., and Roy G. Brower, M.D. N Engl J Med 2015; 372:747-755 February 19, 2015 DOI: 10.1056/NEJMsa1410639 BACKGROUND Mechanical-ventilation strategies that use lower end-inspiratory (plateau) airway pressures, lower tidal volumes (V T ), and higher positive end-expiratory pressures (PEEPs) can improve survival in patients with the acute respiratory distress syndrome (ARDS), but the relative importance of each of these components is uncertain. Because respiratory-system compliance (C RS ) is strongly related to the volume of aerated remaining functional lung during disease (termed functional lung size)...

Anaphylaxis updates part 2- Empty Ventricle Syndrome

Patients with anaphylaxis should not suddenly sit, stand, or be placed in the upright position. Instead, they should be placed on the back with their lower extremities elevated or, if they are experiencing respiratory distress or vomiting, they should be placed in a position of comfort with their lower extremities elevated. This accomplishes 2 therapeutic goals: 1) preservation of fluid in the circulation (the central vascular compartment), an important step in managing distributive shock; and 2) prevention of the empty vena cava/empty ventricle syndrome, which can occur within seconds when patients with anaphylaxis suddenly assume or are placed in an upright position. Patients with this syndrome are at high risk for sudden death. They are unlikely to respond to epinephrine regardless of route of administration, because it does not reach the heart and therefore cannot be circulated throughout the body

Epidural catheter tests...not only the test dose

Siphon test The catheter is held upright and a fluid level sought. If the catheter is then elevated, the fluid level should fall (see inset) as the fluid siphons in to the epidural space, which is usually under negative pressure compared with atmospheric. If the fluid column continues to rise, this may suggest subarachnoid placement. The siphon test can be reassuring, but is not mandatory. Aspiration  This should be considered mandatory. The Luer connector is attached to the catheter and a syringe is used to apply negative pressure. Free and continued aspiration of clear fluid can indicate subarachnoid placement of the catheter. However, if saline has been used for loss of resistance, it is not unusual for a small amount of this to be aspirated. If there is doubt, the aspirated fluid can be tested for glucose (cerebrospinal fluid will generally test positive) or mixed with thiopentone (cerebrospinal fluid forms a precipitate). If blood is freely and continuously aspirated, this sug...